allarity.com (ALLR) Price to Earnings Ratio

Corporate emblem and logo of Allarity Therapeutics Inc. (ALLR)

The daily price chart for Allarity Therapeutics (ALLR) with the -0.90 indicator reflects the business dynamics of its precision oncology operations, which rely on the development of the DRP system and the study of stenoparib. Unique patent protection and strict FDA oversight create high barriers to entry for competitors. Meanwhile, Allarity Therapeutics (ALLR) adheres to standard environmental regulations, ensuring safe waste disposal and energy efficiency within its laboratories.

Allarity Therapeutics, Inc. (ALLR): Price to Earnings Ratio from 08/29/2022 to 11/17/2026

Analytical breakdowns for Allarity Therapeutics

- stock quotes and analyst forecast:
General company analysis:ALLR, Allarity Therapeutics Inc.
Original product of Allarity Therapeutics, Inc.

The P/E ratio determines the cost per unit of profit, calculated as the ratio of the market price per share to the company's net income per share. The current value of -0.90 for the P/E fundamental multiple of Allarity Therapeutics (ALLR) reflects market expectations for the DRP platform under strict FDA oversight, confirming the asset's resilience due to a high patent barrier in oncology.